Skip to main content

. 1963 Aug;39(454):480–483. doi: 10.1136/pgmj.39.454.480

Observations on the Hæmorrhagic Diathesis in Multiple Myeloma

Rosalinde Hurley, Sidney Shaw

PMCID: PMC2482281 PMID: 13955847

480

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

ANDRE R., DREYFUS B., JACOB S., LEY G. Sur les formes hémorragiques des myélomes. Rev Hematol. 1952;7(2):296–305. [PubMed] [Google Scholar]
BERNARD J., INCEMAN S., ZARA M., CHRISTOL D. La dysglobulinémie maligne hémorragipare. Rev Hematol. 1952;7(2):264–295. [PubMed] [Google Scholar]
CRADDOCK C. G., Jr, ADAMS W. S., FIGUEROA W. G. Interference with fibrin formation in multiple myeloma by an unusual protein found in blood and urine. J Lab Clin Med. 1953 Dec;42(6):847–859. [PubMed] [Google Scholar]
FRICK P. G. Inhibition of conversion of fibrinogen to fibrin by abnormal proteins in multiple myeloma. Am J Clin Pathol. 1955 Nov;25(11):1263–1273. doi: 10.1093/ajcp/25.11.1263. [DOI] [PubMed] [Google Scholar]
LUSCHER E., LABHART A. Blutgerinnungsstörung durch beta gamma-Globuline; zur Kenntnis der Gerinnungsstörungen durch körpereigene Antikoagulantien. Schweiz Med Wochenschr. 1949 Jul 2;79(26):598–604. [PubMed] [Google Scholar]
OSSERMAN E. F. Plasma-cell myeloma. II. Clinical aspects. N Engl J Med. 1959 Nov 5;261:952–cont'd. doi: 10.1056/NEJM195911052611906. [DOI] [PubMed] [Google Scholar]
VERSTRAETE M., VERMYLEN C. [Research on antithrombin V in Kahler's disease]. Acta Haematol. 1959 Oct;22:240–254. doi: 10.1159/000205780. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES